Posted: June 3, 2019
Media Contact: Caitlyn Barrett
National Director, Research and Programs
Phone: (240) 235-2215 | firstname.lastname@example.org
CureSearch for Children’s Cancer Announces
Research Award Opportunities
Up to $5 million in research awards will accelerate the development of better, less-toxic children’s cancer treatments
Bethesda, MD – June 3, 2019 – CureSearch for Children’s Cancer announced a request for applications (RFA) for novel drug development projects that address areas of unmet need in pediatric cancer.
The awards will support revolutionary research proposed by investigators worldwide through three CureSearch grant programs:
- Young Investigators Award: Provides seed funding for bright researchers, early in their careers, pursuing exciting, high-potential therapies with the goal of reaching the clinic in three to five years.
- Acceleration Initiative Award: Addresses the largest obstacles in children’s cancer research to propel treatments from the lab to the clinic.
- Catapult Award: Advances the strongest research by funding clinical trials, driving treatments towards regulatory approval while immediately improving patient outcomes.
The application window opened Monday, June 3, 2019 via ProposalCENTRAL; award notifications will be released starting January 2020, on a rolling basis.
CureSearch identifies and funds promising research projects with an accelerated development time frame to meet our end goal—bringing new treatments quickly to the clinic to save kids now. CureSearch’s mission to end children’s cancer includes supporting researchers through funding, guidance, knowledge and relationships to ensure the greatest chance of success.
About CureSearch for Children’s Cancer
CureSearch for Children’s Cancer, a national nonprofit organization based in Bethesda, Md., works to end childhood cancer by driving targeted and innovative research with measurable results in an accelerated time frame. CureSearch focuses on advancing the strongest research out of the laboratory and into clinical trials and development, where better, less-toxic treatments can quickly help children.